FDA phasing out asthma inhalers that use CFCs

by: Jason Stoogenke Updated:


CHARLOTTE, N.C. - The U.S. Food and Drug Administration is phasing out asthma inhalers that use chlorofluorocarbons, otherwise known as CFC, because they are harmful to the ozone layer.

Action 9 Investigator Jason Stoogenke has more on the big question. Will the new ones be as effective?

Patients want to make sure the new ones work well too.

"Having an asthma attack is the worst," Candice Curry said. "Your chest starts feeling like it's closing up."

She said, "You can feel like your breath gets shorter. It gets harder and harder to take a deep breath."

Her inhaler works instantly when every second matters.

"As soon as you take the inhaler, you can feel it open up a little bit, you can actually feel the medicine going down into your lungs, trying to open them back up," she said.

Now, the FDA is close to phasing out the last of the old inhalers by the end of the year.

Local pharmacies like Le's Pharmacy and Moe's Clinic Pharmacy said they switched over a year ago.

Moe's owner said they are just as good as the old ones. The medicine is the same but the propellant is different.

"The effectiveness is the same, but the harmfulness is gone," Moe Khordehforosh said.

"There are many safe and effective inhalers available to treat asthma," an official with the FDA wrote in an email.